東華大學圖書館 |

語系: 繁體中文

說明(常見問題)

回圖書館首頁

手機版館藏查詢

登入

回首頁

切換: 標籤 | MARC模式 | ISBD

FindBook

Google Book

Amazon

博客來

A Connectivity Mapping Approach to Identifying Senolytic Compounds.

紀錄類型:	書目-電子資源 : Monograph/item
正題名/作者:	A Connectivity Mapping Approach to Identifying Senolytic Compounds./
作者:	White, Jessica B.
出版者:	Ann Arbor : ProQuest Dissertations & Theses, : 2021,
面頁冊數:	62 p.
附註:	Source: Masters Abstracts International, Volume: 83-03.
Contained By:	Masters Abstracts International83-03.
標題:	Bioinformatics. -
電子資源:	http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28548918
ISBN:	9798538108084

A Connectivity Mapping Approach to Identifying Senolytic Compounds.
White, Jessica B.

A Connectivity Mapping Approach to Identifying Senolytic Compounds. - Ann Arbor : ProQuest Dissertations & Theses, 2021 - 62 p.

Source: Masters Abstracts International, Volume: 83-03.

Thesis (M.S.)--Weill Medical College of Cornell University, 2021.

This item must not be sold to any third party vendors.

Drug repurposing and in silico identification of promising compounds and mechanisms are two promising methods for reducing the cost and time associated with drug development. Utilizing a robust, open-source database of drug intervention transcriptional profiles, we have developed a workflow to identify compounds potentially capable of reversing the expression signatures of disease and biological states of interest. By modifying an existing protocol, this workflow improves the speed, statistical power, and memory requirements of the standard algorithm associated with this database. We initially validated the revised algorithm using transcriptional profiles of constructs where genes of druggable targets were overexpressed. Having confirmed that the relevant drugs and mechanisms were recovered, we further applied the tool to identify chemical compounds capable of reversing cellular senescence. First, we utilized cell line specific profiles where senescence was induced with various methods. This led us to identify disparate compounds in different cell lines, specifically GSK3i CHIR-99021 and PLKi BI-2536 in endothelial cells and Bcr-Abl/Src inhibitor dasatinib in fibroblast cells. One drug, RAFi SB590885, emerged as a top hit across cell types. We then applied the workflow in more heterogeneous tumor samples exhibiting transcriptional markers of senescence. We found similar compounds were able to reverse these signatures as in the senescent cell line profiles. Dasatinib, in particular, emerged as a top hit both based on the frequency of its occurrence and the strength of its ability to reverse the transcriptional signature.

ISBN: 9798538108084Subjects--Topical Terms:

553671
Bioinformatics.
Subjects--Index Terms:

Connectivity mapping

A Connectivity Mapping Approach to Identifying Senolytic Compounds.
LDR:02683nmm a2200325 4500 001 2345672
005 20220613063751.5
008 241004s2021 ||||||||||||||||| ||eng d
020 $a 9798538108084
035 $a (MiAaPQ)AAI28548918
035 $a AAI28548918
040 $a MiAaPQ $c MiAaPQ
100 1 $a White, Jessica B. $0 (orcid)0000-0001-5748-8383 $3 3684653
245 1 0 $a A Connectivity Mapping Approach to Identifying Senolytic Compounds.
260 1 $a Ann Arbor : $b ProQuest Dissertations & Theses, $c 2021
300 $a 62 p.
500 $a Source: Masters Abstracts International, Volume: 83-03.
500 $a Advisor: Elemento, Olivier.
502 $a Thesis (M.S.)--Weill Medical College of Cornell University, 2021.
506 $a This item must not be sold to any third party vendors.
520 $a Drug repurposing and in silico identification of promising compounds and mechanisms are two promising methods for reducing the cost and time associated with drug development. Utilizing a robust, open-source database of drug intervention transcriptional profiles, we have developed a workflow to identify compounds potentially capable of reversing the expression signatures of disease and biological states of interest. By modifying an existing protocol, this workflow improves the speed, statistical power, and memory requirements of the standard algorithm associated with this database. We initially validated the revised algorithm using transcriptional profiles of constructs where genes of druggable targets were overexpressed. Having confirmed that the relevant drugs and mechanisms were recovered, we further applied the tool to identify chemical compounds capable of reversing cellular senescence. First, we utilized cell line specific profiles where senescence was induced with various methods. This led us to identify disparate compounds in different cell lines, specifically GSK3i CHIR-99021 and PLKi BI-2536 in endothelial cells and Bcr-Abl/Src inhibitor dasatinib in fibroblast cells. One drug, RAFi SB590885, emerged as a top hit across cell types. We then applied the workflow in more heterogeneous tumor samples exhibiting transcriptional markers of senescence. We found similar compounds were able to reverse these signatures as in the senescent cell line profiles. Dasatinib, in particular, emerged as a top hit both based on the frequency of its occurrence and the strength of its ability to reverse the transcriptional signature.
590 $a School code: 0967.
650 4 $a Bioinformatics. $3 553671
650 4 $a Leukemia. $3 677274
650 4 $a Chemical compounds. $3 3684654
650 4 $a Disease. $3 705846
650 4 $a Cancer therapies. $3 3557730
650 4 $a DNA damage. $3 916185
650 4 $a Drugs. $3 617161
650 4 $a Genotype & phenotype. $3 3561790
650 4 $a Apoptosis. $3 600650
650 4 $a Kinases. $3 3558077
650 4 $a Radiation. $3 673904
650 4 $a Gene expression. $3 643979
650 4 $a Dopamine. $3 1362554
650 4 $a Cyclin-dependent kinases. $3 868634
650 4 $a Chromosomes. $3 638948
650 4 $a Antigens. $3 700737
650 4 $a Algorithms. $3 536374
650 4 $a Tumors. $3 893964
650 4 $a Systematic biology. $3 3173492
653 $a Connectivity mapping
653 $a Senolytic compounds
690 $a 0715
690 $a 0423
710 2 $a Weill Medical College of Cornell University. $b Computational Biology and Medicine. $3 3344504
773 0 $t Masters Abstracts International $g 83-03.
790 $a 0967
791 $a M.S.
792 $a 2021
793 $a English
856 4 0 $u http://pqdd.sinica.edu.tw/twdaoapp/servlet/advanced?query=28548918